Lead the Path to Autoimmune Innovation
The 3rd Cell Therapy for Autoimmune Disease Summit, connected a community of 130+ strong scientific pioneers, C-suite executives, VPs and directors driving innovative cell therapies across a wealth of autoimmune indications.
Attendees delved into the latest data, shared proven strategies and unpacked first-hand experiences to propel their pipeline from preclinical innovation to clinical success. Featuring a 80% new speaker faculty, 11 new companies and preclinical and clinical showcases, guests were represented at the only meeting translating cell therapy potential in autoimmunity into reality.
![CB-CDx-0107-min-scaled11[1]](https://cell-therapy-autoimmune-disease.com/wp-content/uploads/sites/286/2026/02/CB-CDx-0107-min-scaled111.jpg "CB-CDx-0107-min-scaled11[1]")
What You Missed in 2025:
3 days of immersive tailored learning, no matter your stage of development, our tracked structure extended to the workshop day. Whether you were pivoting from oncology or were a seasoned expert in autoimmunity, you delved into solutions addressing your most pressing challenges.
Bridged the gap between science and strategy in our search and evaluation pharma insights panel. We helped align your pipeline expansion with industry developments and uncovered new partnership opportunities.
Deep dives into rapidly emerging in vivo therapies, and how these reshaped the course for autoimmune pipelines.
Accessed a breadth of content, from preclinical and translational to clinical development, to keynote presentations and discussions, we equipped your scientific and corporate development teams for therapeutic success.
We Empowered Your Team to Accelerate Clinical Success in 2025:
To maximize your team's take home learnings and enhance cross-functional collaborations, the 2025 agenda was expertly curated across two tracks. We attracted representation from C-suite leaders to scientific and business development teams, and fast-tracked your pipeline progression!
Preclinical & Translational Track
Designed for R&D, preclinical, translational, regulatory and scientific leads, these sessions will tackle critical challenges in treatment scale-up, autologous and allogeneic development, and cell targeting.
Clinical Track
Crafted for clinical development, regulatory affairs, translational medicine and medical affairs experts, these presentations seek to improve biomarker use, BLA readiness, clinical trial design and patient recruitment processes.
Access Your Copy of the 2025 Event Program to Discover:
- An expanded speaker line-up, including 80% new experts
- 17+ hours of interactive sessions and discussions
- A brand-new two-tracked Pre-Conference Workshop Day
- New preclinical and clinical autoimmune data showcases
Who Did You Meet in 2025?
![CB-CDx-0690-min-scaled11[1]](https://cell-therapy-autoimmune-disease.com/wp-content/uploads/sites/286/2024/06/CB-CDx-0690-min-scaled111.jpg "CB-CDx-0690-min-scaled11[1]")
Explore the 2025 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.